Open AccessP925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)
Author(s) -
Lee H. C.,
Ramasamy K.,
Macro M.,
Davies F. E.,
Abonour R.,
Rhee F.,
Hungria V. T.,
Puig N.,
Ren K.,
Silar J.,
Enwemadu V.,
Cherepanov D.,
Stull D. M.,
Leleu X.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846568.99304.59
Subject(s) - lenalidomide , medicine , ixazomib , multiple myeloma , adverse effect , oncology , hazard ratio , surgery , confidence interval , carfilzomib